메뉴 건너뛰기




Volumn 160, Issue 5, 2010, Pages

Design and rationale of the Reduction of Infarct Expansion and Ventricular Remodeling with Erythropoietin after Large Myocardial Infarction (REVEAL) trial

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; RECOMBINANT ERYTHROPOIETIN;

EID: 78649377581     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2010.09.007     Document Type: Article
Times cited : (19)

References (59)
  • 1
    • 37849041229 scopus 로고    scopus 로고
    • 2007 Focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines
    • Antman E.M., Hand M., and Armstrong P.W. 2007 Focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines J Am Coll Cardiol 51 2008 210 247
    • (2008) J Am Coll Cardiol , vol.51 , pp. 210-247
    • Antman, E.M.1    Hand, M.2    Armstrong, P.W.3
  • 2
    • 34247854930 scopus 로고    scopus 로고
    • Decline in rates of death and heart failure in acute coronary syndromes, 1999-2006
    • Fox K.A., Steg P.G., and Eagle K.A. Decline in rates of death and heart failure in acute coronary syndromes, 1999-2006 JAMA 297 2007 1892 1900
    • (2007) JAMA , vol.297 , pp. 1892-1900
    • Fox, K.A.1    Steg, P.G.2    Eagle, K.A.3
  • 3
    • 0025266820 scopus 로고
    • Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications
    • Pfeffer M., and Braunwald E. Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications Circulation 81 1990 1161 1172
    • (1990) Circulation , vol.81 , pp. 1161-1172
    • Pfeffer, M.1    Braunwald, E.2
  • 4
    • 31144476692 scopus 로고    scopus 로고
    • Comparison between contrast echocardiography and magnetic resonance imaging to predict improvement of myocardial function after primary coronary intervention
    • Biagini E., van Geuns R.J., and Baks T. Comparison between contrast echocardiography and magnetic resonance imaging to predict improvement of myocardial function after primary coronary intervention Am J Cardiol 97 2006 361 366
    • (2006) Am J Cardiol , vol.97 , pp. 361-366
    • Biagini, E.1    Van Geuns, R.J.2    Baks, T.3
  • 5
    • 51549089000 scopus 로고    scopus 로고
    • Prognostic implications of left ventricular mass and geometry following myocardial infarction: The VALIANT (VALsartan in Acute myocardial iNfarcTion) Echocardiographic Study
    • Verma A., Meris A., and Skali H. Prognostic implications of left ventricular mass and geometry following myocardial infarction: the VALIANT (VALsartan In Acute myocardial iNfarcTion) Echocardiographic Study JACC Cardiovasc Imaging 1 2008 582 591
    • (2008) JACC Cardiovasc Imaging , vol.1 , pp. 582-591
    • Verma, A.1    Meris, A.2    Skali, H.3
  • 6
    • 33845981823 scopus 로고    scopus 로고
    • Pexelizumab for acute ST-elevation myocardial infarction in patients undergoing primary percutaneous coronary intervention
    • The APEX Investigators Pexelizumab for acute ST-elevation myocardial infarction in patients undergoing primary percutaneous coronary intervention A randomized controlled trial. JAMA 297 2007 43 51
    • (2007) A Randomized Controlled Trial. JAMA , vol.297 , pp. 43-51
  • 7
    • 0035808003 scopus 로고    scopus 로고
    • Double-blind, randomized trial of an anti-CD18 antibody in conjunction with recombinant tissue plasminogen activator for acute myocardial infarction: Limitation of myocardial infarction following thrombolysis in acute myocardial infarction (LIMIT AMI) study
    • Baran K.W., Nguyen M., and McKendall G.R. Double-blind, randomized trial of an anti-CD18 antibody in conjunction with recombinant tissue plasminogen activator for acute myocardial infarction: limitation of myocardial infarction following thrombolysis in acute myocardial infarction (LIMIT AMI) study Circulation 104 2001 2778 2783
    • (2001) Circulation , vol.104 , pp. 2778-2783
    • Baran, K.W.1    Nguyen, M.2    McKendall, G.R.3
  • 8
    • 0037010009 scopus 로고    scopus 로고
    • The effect of blockade of the CD11/CD18 integrin receptor on infarct size in patients with acute myocardial infarction treated with direct angioplasty: The results of the HALT-MI study
    • Faxon D.P., Gibbons R.J., and Chronos N.A. The effect of blockade of the CD11/CD18 integrin receptor on infarct size in patients with acute myocardial infarction treated with direct angioplasty: the results of the HALT-MI study J Am Coll Cardiol 40 2002 1199 1204
    • (2002) J Am Coll Cardiol , vol.40 , pp. 1199-1204
    • Faxon, D.P.1    Gibbons, R.J.2    Chronos, N.A.3
  • 9
    • 6344225691 scopus 로고    scopus 로고
    • Erythropoietin receptor expression in adult rat cardiomyocytes is associated with an acute cardioprotective effect for recombinant erythropoietin during ischemia-reperfusion injury
    • Wright G.L., Hanlon P., and Amin K. Erythropoietin receptor expression in adult rat cardiomyocytes is associated with an acute cardioprotective effect for recombinant erythropoietin during ischemia-reperfusion injury FASEB 18 2004 1031 1033
    • (2004) FASEB , vol.18 , pp. 1031-1033
    • Wright, G.L.1    Hanlon, P.2    Amin, K.3
  • 10
    • 0038163900 scopus 로고    scopus 로고
    • Hearts from rodents exposed to intermittent hypoxia or erythropoietin are protected against ischemia-reperfusion injury
    • Cai Z., Manalo D.J., and Wei G. Hearts from rodents exposed to intermittent hypoxia or erythropoietin are protected against ischemia-reperfusion injury Circulation 108 2003 79 85
    • (2003) Circulation , vol.108 , pp. 79-85
    • Cai, Z.1    Manalo, D.J.2    Wei, G.3
  • 11
    • 85047691007 scopus 로고    scopus 로고
    • A novel protective effect of erythropoietin in the infarcted heart
    • Parsa C.J., Matsumoto A., and Kim J. A novel protective effect of erythropoietin in the infarcted heart J Clin Invest 112 2003 999 1007
    • (2003) J Clin Invest , vol.112 , pp. 999-1007
    • Parsa, C.J.1    Matsumoto, A.2    Kim, J.3
  • 12
    • 0141593556 scopus 로고    scopus 로고
    • Erythropoietin reduces myocardial infarction and left ventricular functional decline after coronary artery ligation in rats
    • Moon C., Krawczyk M., and Ahn D. Erythropoietin reduces myocardial infarction and left ventricular functional decline after coronary artery ligation in rats Proc Natl Acad Sci U S A 100 2003 11612 11617
    • (2003) Proc Natl Acad Sci U S A , vol.100 , pp. 11612-11617
    • Moon, C.1    Krawczyk, M.2    Ahn, D.3
  • 13
    • 33845225092 scopus 로고    scopus 로고
    • Protective effects of erythropoietin in cardiac ischemia: From bench to bedside
    • Lipšic E., Schoemaker R.G., and van der Meer P. Protective effects of erythropoietin in cardiac ischemia: from bench to bedside J Am Coll Cardiol 48 2006 2161 2167
    • (2006) J Am Coll Cardiol , vol.48 , pp. 2161-2167
    • Lipšic, E.1    Schoemaker, R.G.2    Van Der Meer, P.3
  • 14
    • 21344459065 scopus 로고    scopus 로고
    • Erythropoietin induces neovascularization and improves cardiac function in rats with heart failure after myocardial infarction
    • van der Meer P., Lipšic E., and Henning R.H. Erythropoietin induces neovascularization and improves cardiac function in rats with heart failure after myocardial infarction J Am Coll Cardiol 46 2005 125 133
    • (2005) J Am Coll Cardiol , vol.46 , pp. 125-133
    • Van Der Meer, P.1    Lipšic, E.2    Henning, R.H.3
  • 15
    • 37549020370 scopus 로고    scopus 로고
    • Low-dose erythropoietin improves cardiac function in experimental heart failure without increasing haematocrit
    • Lipšic E., Westenbrink B.D., and van der Meer P. Low-dose erythropoietin improves cardiac function in experimental heart failure without increasing haematocrit Eur J Heart Fail 10 2008 22 29
    • (2008) Eur J Heart Fail , vol.10 , pp. 22-29
    • Lipšic, E.1    Westenbrink, B.D.2    Van Der Meer, P.3
  • 16
    • 33745250458 scopus 로고    scopus 로고
    • Erythropoietin enhances neovascularization of ischemic myocardium and improves left ventricular dysfunction after myocardial infarction in dogs
    • Hirata A., Minamino T., and Asanuma H. Erythropoietin enhances neovascularization of ischemic myocardium and improves left ventricular dysfunction after myocardial infarction in dogs J Am Coll Cardiol 48 2006 176 184
    • (2006) J Am Coll Cardiol , vol.48 , pp. 176-184
    • Hirata, A.1    Minamino, T.2    Asanuma, H.3
  • 17
    • 0037458127 scopus 로고    scopus 로고
    • Effect of erythropoietin on exercise capacity in patients with moderate to severe chronic heart failure
    • Mancini D.M., Katz S.D., and Lang C.C. Effect of erythropoietin on exercise capacity in patients with moderate to severe chronic heart failure Circulation 107 2003 294 299
    • (2003) Circulation , vol.107 , pp. 294-299
    • Mancini, D.M.1    Katz, S.D.2    Lang, C.C.3
  • 18
    • 0036705708 scopus 로고    scopus 로고
    • Erythropoietin therapy for acute stroke is both safe and beneficial
    • Ehrenreich H., Hasselblatt M., and Dembowski C. Erythropoietin therapy for acute stroke is both safe and beneficial Mol Med 8 2002 495 505
    • (2002) Mol Med , vol.8 , pp. 495-505
    • Ehrenreich, H.1    Hasselblatt, M.2    Dembowski, C.3
  • 19
    • 57549083429 scopus 로고    scopus 로고
    • Effect of EPO administration on myocardial infarct size in patients with non-STE acute coronary syndromes; Results from a pilot study
    • Liem A., van de Woestijne A.P., and Bruijns E. Effect of EPO administration on myocardial infarct size in patients with non-STE acute coronary syndromes; results from a pilot study Int J Cardiol 131 2009 285 287
    • (2009) Int J Cardiol , vol.131 , pp. 285-287
    • Liem, A.1    Van De Woestijne, A.P.2    Bruijns, E.3
  • 20
    • 70949095435 scopus 로고    scopus 로고
    • Recombinant human erythropoietin in the treatment of acute ischemic stroke
    • Ehrenreich H., Weissenborn K., and Prange H. Recombinant human erythropoietin in the treatment of acute ischemic stroke Stroke 40 2009 e647 56
    • (2009) Stroke , vol.40 , pp. 647-656
    • Ehrenreich, H.1    Weissenborn, K.2    Prange, H.3
  • 21
    • 41049115024 scopus 로고    scopus 로고
    • Randomized double-blind trial of darbepoetin alfa in patients with symptomatic heart failure and anemia
    • Ghali J.K., Anand I.S., and Abraham W.T. Randomized double-blind trial of darbepoetin alfa in patients with symptomatic heart failure and anemia Circulation 117 2008 526 535
    • (2008) Circulation , vol.117 , pp. 526-535
    • Ghali, J.K.1    Anand, I.S.2    Abraham, W.T.3
  • 22
    • 78349287458 scopus 로고    scopus 로고
    • Erythropoietin in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: A randomized, double-blind trial
    • Ott I., Schulz S., and Mehilli J. Erythropoietin in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a randomized, double-blind trial Circ Cardiovasc Interv 2010 [Epub ahead of print]. DOI: 10.1161/CIRCINTERVENTIONS.109.904425
    • (2010) Circ Cardiovasc Interv
    • Ott, I.1    Schulz, S.2    Mehilli, J.3
  • 23
    • 40149083005 scopus 로고    scopus 로고
    • Performance of delayed-enhancement MRI using gadoversetamide contrast for the detection and assessment of myocardial infarction: An international, multicenter, double-blinded, randomized trial
    • Kim R.J., Albert T.S., and Wible J.H. Performance of delayed-enhancement MRI using gadoversetamide contrast for the detection and assessment of myocardial infarction: an international, multicenter, double-blinded, randomized trial Circulation 117 2008 629 637
    • (2008) Circulation , vol.117 , pp. 629-637
    • Kim, R.J.1    Albert, T.S.2    Wible, J.H.3
  • 24
    • 73649092447 scopus 로고    scopus 로고
    • Pexelizumab and infarct size in patients with acute myocardial infarction undergoing primary PCI: A delayed enhancement cardiac magnetic resonance substudy from the APEX-AMI trial
    • Patel M.R., Worthley S.G., and Stebbins A. Pexelizumab and infarct size in patients with acute myocardial infarction undergoing primary PCI: a delayed enhancement cardiac magnetic resonance substudy from the APEX-AMI trial JACC Cardiovasc Imaging 3 2010 52 60
    • (2010) JACC Cardiovasc Imaging , vol.3 , pp. 52-60
    • Patel, M.R.1    Worthley, S.G.2    Stebbins, A.3
  • 25
    • 58649089789 scopus 로고    scopus 로고
    • Common endothelial progenitor cell assays identify discrete endothelial progenitor cell populations
    • Povsic T.J., Zavodni K.L., and Vainorius E. Common endothelial progenitor cell assays identify discrete endothelial progenitor cell populations Am Heart J 157 2009 335 344
    • (2009) Am Heart J , vol.157 , pp. 335-344
    • Povsic, T.J.1    Zavodni, K.L.2    Vainorius, E.3
  • 26
    • 70349092726 scopus 로고    scopus 로고
    • Aldehyde dehydrogenase activity allows reliable EPC enumeration in stored peripheral blood samples
    • Povsic T.J., Adams S.D., and Zavodni K.L. Aldehyde dehydrogenase activity allows reliable EPC enumeration in stored peripheral blood samples J Thromb Thrombolysis 28 2009 259 265
    • (2009) J Thromb Thrombolysis , vol.28 , pp. 259-265
    • Povsic, T.J.1    Adams, S.D.2    Zavodni, K.L.3
  • 27
    • 34247558672 scopus 로고    scopus 로고
    • Clinical end points in coronary stent trials: A case for standardized definitions
    • Cutlip D.E., Windecker S., and Mehran R. Clinical end points in coronary stent trials: a case for standardized definitions Circulation 115 2007 2344 2351
    • (2007) Circulation , vol.115 , pp. 2344-2351
    • Cutlip, D.E.1    Windecker, S.2    Mehran, R.3
  • 28
    • 56349124221 scopus 로고    scopus 로고
    • Erythropoietin in heart and vessels: Focus on transcription and signalling pathways
    • Marzo F., Lavorgna A., and Coluzzi G. Erythropoietin in heart and vessels: focus on transcription and signalling pathways J Thromb Thrombolysis 26 2008 183 187
    • (2008) J Thromb Thrombolysis , vol.26 , pp. 183-187
    • Marzo, F.1    Lavorgna, A.2    Coluzzi, G.3
  • 30
    • 0042738942 scopus 로고    scopus 로고
    • Erythropoietin is a potent physiologic stimulus for endothelial progenitor cell mobilization
    • Heeschen C., Aicher A., and Lehmann R. Erythropoietin is a potent physiologic stimulus for endothelial progenitor cell mobilization Blood 102 2003 1340 1346
    • (2003) Blood , vol.102 , pp. 1340-1346
    • Heeschen, C.1    Aicher, A.2    Lehmann, R.3
  • 31
    • 9144258353 scopus 로고    scopus 로고
    • Erythropoietin regulates endothelial progenitor cells
    • Bahlmann F.H., De Groot K., and Spandau J.M. Erythropoietin regulates endothelial progenitor cells Blood 103 2004 921 926
    • (2004) Blood , vol.103 , pp. 921-926
    • Bahlmann, F.H.1    De Groot, K.2    Spandau, J.M.3
  • 33
    • 33745395054 scopus 로고    scopus 로고
    • Erythropoietin-mobilized endothelial progenitors enhance reendothelialization via Akt-endothelial nitric oxide synthase activation and prevent neointimal hyperplasia
    • Urao N., Okigaki M., and Yamada H. Erythropoietin-mobilized endothelial progenitors enhance reendothelialization via Akt-endothelial nitric oxide synthase activation and prevent neointimal hyperplasia Circ Res 98 2006 1405 1413
    • (2006) Circ Res , vol.98 , pp. 1405-1413
    • Urao, N.1    Okigaki, M.2    Yamada, H.3
  • 34
    • 0025297296 scopus 로고
    • Erythropoietin has a mitogenic and positive chemotactic effect on endothelial cells
    • Anagnostou A., Lee E.S., and Kessimian N. Erythropoietin has a mitogenic and positive chemotactic effect on endothelial cells Proc Natl Acad Sci U S A 87 1990 5978 5982
    • (1990) Proc Natl Acad Sci U S A , vol.87 , pp. 5978-5982
    • Anagnostou, A.1    Lee, E.S.2    Kessimian, N.3
  • 35
    • 0035894847 scopus 로고    scopus 로고
    • Erythropoietin regulates the in vitro and in vivo production of neuronal progenitors by mammalian forebrain neural stem cells
    • Shingo T., Sorokan S.T., and Shimazaki T. Erythropoietin regulates the in vitro and in vivo production of neuronal progenitors by mammalian forebrain neural stem cells J Neurosci 21 2001 9733 9743
    • (2001) J Neurosci , vol.21 , pp. 9733-9743
    • Shingo, T.1    Sorokan, S.T.2    Shimazaki, T.3
  • 36
    • 70350523713 scopus 로고    scopus 로고
    • Update on phase II studies of erythropoietin in acute myocardial infarction. Rationale and design of Exogenous erythroPoietin in Acute Myocardial Infarction: New Outlook and Dose Association Study (EPAMINONDAS)
    • Andreotti F., Agati L., and Conti E. Update on phase II studies of erythropoietin in acute myocardial infarction. Rationale and design of Exogenous erythroPoietin in Acute Myocardial Infarction: New Outlook aNd Dose Association Study (EPAMINONDAS) J Thromb Thrombolysis 28 2009 48995 (EudraCTno. 200500485386)
    • (2009) J Thromb Thrombolysis , vol.28 , pp. 48995
    • Andreotti, F.1    Agati, L.2    Conti, E.3
  • 38
    • 3142598688 scopus 로고    scopus 로고
    • An update on the cardiac effects of erythropoietin cardioprotection by erythropoietin and the lessons learnt from studies in neuroprotection
    • Bogoyevitch M.A. An update on the cardiac effects of erythropoietin cardioprotection by erythropoietin and the lessons learnt from studies in neuroprotection Cardiovasc Res 63 2004 208 216
    • (2004) Cardiovasc Res , vol.63 , pp. 208-216
    • Bogoyevitch, M.A.1
  • 39
    • 6944237300 scopus 로고    scopus 로고
    • Erythropoietin mediates tissue protection through an erythropoietin and common beta-subunit heteroreceptor
    • Brines M., Grasso G., and Fiordaliso F. Erythropoietin mediates tissue protection through an erythropoietin and common beta-subunit heteroreceptor Proc Natl Acad Sci U S A 101 2004 14907 14912
    • (2004) Proc Natl Acad Sci U S A , vol.101 , pp. 14907-14912
    • Brines, M.1    Grasso, G.2    Fiordaliso, F.3
  • 40
    • 0041659121 scopus 로고    scopus 로고
    • Erythropoietin protects cardiac myocytes from hypoxia-induced apoptosis through an Akt-dependent pathway
    • Tramontano A.F., Muniyappa R., and Black A.D. Erythropoietin protects cardiac myocytes from hypoxia-induced apoptosis through an Akt-dependent pathway Biochem Biophys Res Commun 308 2003 990 994
    • (2003) Biochem Biophys Res Commun , vol.308 , pp. 990-994
    • Tramontano, A.F.1    Muniyappa, R.2    Black, A.D.3
  • 41
    • 0035044085 scopus 로고    scopus 로고
    • Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function
    • Kocher A.A., Schuster M.D., and Szabolcs M.J. Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function Nat Med 7 2001 430 436
    • (2001) Nat Med , vol.7 , pp. 430-436
    • Kocher, A.A.1    Schuster, M.D.2    Szabolcs, M.J.3
  • 42
    • 0037447256 scopus 로고    scopus 로고
    • Recombinant human erythropoietin protects the myocardium from ischemia-reperfusion injury and promotes beneficial remodeling
    • Calvillo L., Latini R., and Kajstura J. Recombinant human erythropoietin protects the myocardium from ischemia-reperfusion injury and promotes beneficial remodeling Proc Natl Acad Sci U S A 100 2003 4802 4806
    • (2003) Proc Natl Acad Sci U S A , vol.100 , pp. 4802-4806
    • Calvillo, L.1    Latini, R.2    Kajstura, J.3
  • 43
    • 4644227714 scopus 로고    scopus 로고
    • Timing of erythropoietin treatment for cardioprotection in ischemia/reperfusion
    • Lipšic E., van der Meer P., and Henning R.H. Timing of erythropoietin treatment for cardioprotection in ischemia/reperfusion J Cardiovasc Pharmacol 44 2004 473 479
    • (2004) J Cardiovasc Pharmacol , vol.44 , pp. 473-479
    • Lipšic, E.1    Van Der Meer, P.2    Henning, R.H.3
  • 44
    • 28844443403 scopus 로고    scopus 로고
    • Cardioprotection by recombinant human erythropoietin following acute experimental myocardial infarction: Dose response and therapeutic window
    • Moon C., Krawczyk M., and Paik D. Cardioprotection by recombinant human erythropoietin following acute experimental myocardial infarction: dose response and therapeutic window Cardiovasc Drugs Ther 19 2005 243 250
    • (2005) Cardiovasc Drugs Ther , vol.19 , pp. 243-250
    • Moon, C.1    Krawczyk, M.2    Paik, D.3
  • 45
    • 0035370037 scopus 로고    scopus 로고
    • The effect of correction of mild anemia in severe, resistant congestive heart failure using subcutaneous erythropoietin and intravenous iron: A randomized controlled study
    • Silverberg D.S., Wexler D., and Sheps D. The effect of correction of mild anemia in severe, resistant congestive heart failure using subcutaneous erythropoietin and intravenous iron: a randomized controlled study J Am Coll Cardiol 37 2001 1775 1780
    • (2001) J Am Coll Cardiol , vol.37 , pp. 1775-1780
    • Silverberg, D.S.1    Wexler, D.2    Sheps, D.3
  • 46
    • 33845216454 scopus 로고    scopus 로고
    • Erythropoietin improves anemia exercise tolerance and renal function and reduces B-type natriuretic peptide and hospitalization in patients with heart failure and anemia
    • Palazzuoli A., Silverberg D., and Iovine F. Erythropoietin improves anemia exercise tolerance and renal function and reduces B-type natriuretic peptide and hospitalization in patients with heart failure and anemia Am Heart J 152 2006 1096.e9 1096.e15
    • (2006) Am Heart J , vol.152
    • Palazzuoli, A.1    Silverberg, D.2    Iovine, F.3
  • 47
    • 33745025709 scopus 로고    scopus 로고
    • A single bolus of a long-acting erythropoietin analogue darbepoetin alfa in patients with acute myocardial infarction: A randomized feasibility and safety study
    • Lipsic E., van der Meer P., and Voors A.A. A single bolus of a long-acting erythropoietin analogue darbepoetin alfa in patients with acute myocardial infarction: a randomized feasibility and safety study Cardiovasc Drugs Ther 20 2006 135 141
    • (2006) Cardiovasc Drugs Ther , vol.20 , pp. 135-141
    • Lipsic, E.1    Van Der Meer, P.2    Voors, A.A.3
  • 48
    • 77954777322 scopus 로고    scopus 로고
    • High-dose erythropoietin in patients with acute myocardial infarction: A pilot, randomised, placebo-controlled study
    • Ferrario M., Arbustini E., and Massa M. High-dose erythropoietin in patients with acute myocardial infarction: A pilot, randomised, placebo-controlled study Int J Cardiol 2009 [Epub ahead of print]
    • (2009) Int J Cardiol
    • Ferrario, M.1    Arbustini, E.2    Massa, M.3
  • 49
    • 70349492321 scopus 로고    scopus 로고
    • Erythropoietin to augment myocardial salvage induced by coronary thrombolysis in patients with ST segment elevation acute myocardial infarction
    • Binbrek A.S., Rao N.S., and Al Khaja N. Erythropoietin to augment myocardial salvage induced by coronary thrombolysis in patients with ST segment elevation acute myocardial infarction Am J Cardiol 104 2009 1035 1040
    • (2009) Am J Cardiol , vol.104 , pp. 1035-1040
    • Binbrek, A.S.1    Rao, N.S.2    Al Khaja, N.3
  • 50
    • 52449091879 scopus 로고    scopus 로고
    • Erythropoietin in cardioprotection: Does it have a future or is it all in the past?
    • Mehta J.L. Erythropoietin in cardioprotection: does it have a future or is it all in the past? Cardiovasc Res 79 2008 549 550
    • (2008) Cardiovasc Res , vol.79 , pp. 549-550
    • Mehta, J.L.1
  • 51
    • 77958518157 scopus 로고    scopus 로고
    • A single dose of erythropoietin in ST-elevation myocardial infarction
    • Voors A.A., Belonje A.M., and Zijlstra F. A single dose of erythropoietin in ST-elevation myocardial infarction Eur Heart J 2010 Epub ahead of print]. DOI: 10.1093/eurheartj/ehq304
    • (2010) Eur Heart J
    • Voors, A.A.1    Belonje, A.M.2    Zijlstra, F.3
  • 52
    • 43049157887 scopus 로고    scopus 로고
    • New limits advised for anemia drugs
    • Mitka M. New limits advised for anemia drugs JAMA 299 2008 2016
    • (2008) JAMA , vol.299 , pp. 2016
    • Mitka, M.1
  • 54
    • 33846249198 scopus 로고    scopus 로고
    • Rapid detection of myocardial infarction by sub-second, free-breathing delayed contrast-enhancement cardiovascular magnetic resonance
    • Sievers B., Elliott M.D., and Hurwitz L.M. Rapid detection of myocardial infarction by sub-second, free-breathing delayed contrast-enhancement cardiovascular magnetic resonance Circulation 115 2007 236 244
    • (2007) Circulation , vol.115 , pp. 236-244
    • Sievers, B.1    Elliott, M.D.2    Hurwitz, L.M.3
  • 55
    • 45849153884 scopus 로고    scopus 로고
    • Detection of left ventricular thrombus by delayed-enhancement CMR: Prevalence and markers in patients with systolic dysfunction
    • Weinsaft J.W., Kim H.W., and Shah D. Detection of left ventricular thrombus by delayed-enhancement CMR: Prevalence and markers in patients with systolic dysfunction J Am Coll Cardiol 52 2008 148 157
    • (2008) J Am Coll Cardiol , vol.52 , pp. 148-157
    • Weinsaft, J.W.1    Kim, H.W.2    Shah, D.3
  • 56
    • 7544232702 scopus 로고    scopus 로고
    • Clinical indications for cardiovascular magnetic resonance (CMR): Consensus Panel report
    • Pennell D.J., Sechtem U.P., and Higgins C.B. Clinical indications for cardiovascular magnetic resonance (CMR): Consensus Panel report Eur Heart J 25 2004 1940 1965
    • (2004) Eur Heart J , vol.25 , pp. 1940-1965
    • Pennell, D.J.1    Sechtem, U.P.2    Higgins, C.B.3
  • 57
    • 85051643203 scopus 로고    scopus 로고
    • Magnetic resonance imaging of the heart
    • Kim H.W., Farzaneh-Far A., and Klem I. Magnetic resonance imaging of the heart V. Fuster, R.A. O'Rourke, P. Poole-Wilson, Hurst's The Heart 13th ed. 2010 McGraw Hill New York (N.Y.)
    • (2010) Hurst's the Heart
    • Kim, H.W.1    Farzaneh-Far, A.2    Klem, I.3
  • 58
    • 0033539584 scopus 로고    scopus 로고
    • Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function
    • Kim R.J., Fieno D.S., and Parrish T.B. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function Circulation 100 1999 1992 2002
    • (1999) Circulation , vol.100 , pp. 1992-2002
    • Kim, R.J.1    Fieno, D.S.2    Parrish, T.B.3
  • 59
    • 72749099997 scopus 로고    scopus 로고
    • Cardiovascular magnetic resonance in patients with myocardial infarction - Current and emerging applications
    • Kim H.W., Farzaneh-Far A., and Kim R.J. Cardiovascular magnetic resonance in patients with myocardial infarction - current and emerging applications J Am Coll Cardiol 55 2010 1 16
    • (2010) J Am Coll Cardiol , vol.55 , pp. 1-16
    • Kim, H.W.1    Farzaneh-Far, A.2    Kim, R.J.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.